612 results on '"Greuter, Thomas"'
Search Results
2. The Genetics of Inflammatory Bowel Disease
3. Eosinophil Distribution in Eosinophilic Esophagitis and its Impact on Disease Activity and Response to Treatment
4. Endoscopic treatment of nonoperable large postsurgical esophageal fistulas: retrospective analysis of a single tertiary center cohort
5. Endoscopic Features of Eosinophilic Gastrointestinal Diseases
6. A Multicenter Long-Term Cohort Study of Eosinophilic Esophagitis Variants and Their Progression to Eosinophilic Esophagitis Over Time
7. A MULTICENTER LONG-TERM COHORT STUDY OF EOSINOPHILIC ESOPHAGITIS VARIANTS AND THEIR PROGRESSION TO EOE OVER TIME
8. Update zur medikamentösen Therapie der Colitis ulcerosa
9. Advancing patient care through the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR)
10. The personality traits activity, self-reproach, and negative affect jointly predict clinical recurrence, depressive symptoms, and low quality of life in inflammatory bowel disease patients
11. Is There a Role for Topical Swallowed Steroids upon Emergency Room Admission for Suspected Food Bolus Obstruction in Eosinophilic Esophagitis?
12. International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature
13. Mechanotransduction-induced glycolysis epigenetically regulates a CXCL1-dominant angiocrine signaling program in liver sinusoidal endothelial cells in vitro and in vivo
14. Sex Impacts Disease Activity But Not Symptoms or Quality of Life in Adults With Eosinophilic Esophagitis
15. Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study
16. Rationale for an Eosinophilic Esophagitis Treat-to-Target Concept.
17. Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell–Fibroblast Crosstalk
18. Synectin promotes fibrogenesis by regulating PDGFR isoforms through distinct mechanisms
19. Effectiveness and Safety of High- vs Low-Dose Swallowed Topical Steroids for Maintenance Treatment of Eosinophilic Esophagitis: A Multicenter Observational Study
20. Pediatric Patients with Eosinophilic Esophagitis and Their Parents Identify Symptoms as the Most Important Treatment Outcome
21. Endoscopic treatment of non-operable large post-surgical esophageal fistulas: retrospective analysis of a single tertiary center cohort
22. Clinicopathologic Correlations in Eosinophilic Gastrointestinal Disorders
23. Eosinophilic esophagitis—established facts and new horizons
24. High prevalence of short telomeres in idiopathic porto-sinusoidal vascular disorder.
25. Disease Progression and Outcomes of Pregnancies in Women With Eosinophilic Esophagitis
26. Evaluation of Acute Mountain Sickness by Unsedated Transnasal Esophagogastroduodenoscopy at High Altitude
27. GIPC-Regulated IGFBP-3 Promotes HSC Migration In Vitro and Portal Hypertension In Vivo Through a β1-Integrin Pathway
28. Advancing patient care through the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR)
29. Emerging therapies for eosinophilic esophagitis
30. To Scope or Not to Scope, That is the Question
31. Abdominal pain in patients with inflammatory bowel disease: association with single-nucleotide polymorphisms prevalent in irritable bowel syndrome and clinical management
32. Impact of Overweight and Obesity on Disease Outcome in the Pediatric Swiss Inflammatory Bowel Disease Cohort
33. Maintenance Treatment Of Eosinophilic Esophagitis With Swallowed Topical Steroids Alters Disease Course Over A 5-Year Follow-up Period In Adult Patients
34. Enhancer of Zeste Homologue 2 Inhibition Attenuates TGF-β Dependent Hepatic Stellate Cell Activation and Liver Fibrosis
35. The Genetics of Inflammatory Bowel Disease
36. Hepatic Circulation
37. Delayed hypersensitivity reaction to orodispersible budesonide in a case with eosinophilic esophagitis
38. High prevalence of short telomeres in patients with idiopathic porto-sinusoidal vascular disorder
39. Diagnosis and Management of Iron Deficiency in Inflammatory Bowel Disease
40. The perspective of celiac disease patients on emerging treatment options and non-celiac gluten sensitivity
41. ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease.
42. Histological Phenotyping in Eosinophilic Esophagitis: Localized Proximal Disease Is Infrequent but Associated with Less Severe Disease and Better Disease Outcome.
43. Lifting the Veil: The Quest for Noninvasive Biomarkers for the Accurate Diagnosis of Eosinophilic Esophagitis
44. Ascending to New Heights for Novel Therapeutics for Eosinophilic Esophagitis
45. Barrett’s Esophagus in Eosinophilic Esophagitis in Swiss Eosinophilic Esophagitis Cohort Study (SEECS)
46. ECCO Guidelines on Inflammatory Bowel Disease and Malignancies
47. Barrett’s Esophagus in Eosinophilic Esophagitis in Swiss Eosinophilic Esophagitis Cohort Study (SEECS)
48. Celiac disease diagnosis still significantly delayed – Doctor's but not patients’ delay responsive for the increased total delay in women
49. 21. Anämie
50. EoE und EGIDs - Eosinophile Ösophagitis und Eosinophile Gastrointestinale Erkrankungen.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.